A third of GP appointments in June were over the phone or online, data shows
Family doctors said remote consultations 'offer convenience and flexibility that many patients value', and the majority of appointments are still delivered face to face.
As many as four in 10 appointments were carried out by phone or online during the pandemic, but the proportion fell once the impact of Covid-19 eased and had dropped to 27.7% in January 2023.
In the past two years the figure has risen slowly but steadily, driven by a sharp increase in consultations taking place online.
These accounted for only 1.5% of all GP appointments in June 2023 but had jumped to 4.9% by June 2024 and 8.0% in June this year.
This has helped push up the combined figure for phone and online appointments to its current post-pandemic high of 33.3%.
The figure just for telephone appointments has remained broadly unchanged over this period, at about 25%.
Professor Kamila Hawthorne, chairwoman of the Royal College of GPs (RCGP), said: 'Remote consultations, whether delivered over the phone or via video, can offer convenience and flexibility that many patients value, and evidence has shown that in the vast majority of cases, remote care is safe.
'Often a GP might initially consult with a patient remotely and then ask them to come into the practice if it's necessary to see them in person.
'However, we also know that many patients prefer to access their care in-person, and this is how the majority of appointments are still delivered.
'Over the last 12 months, GPs and their teams have delivered a record-breaking number of appointments, and nearly 250 million were carried out in person.'
Some 63.3% of GP appointments in June in England were in person, data shows, down from 65.3% a year earlier and 68.4% in June 2023.
Online appointments include those carried out using live chat tools or non-video apps, as well as video-based calls.
The proportion of appointments taking place by phone or online varies across the regions, with the figures for June ranging from 38.2% in London to 28.4% in North East and Yorkshire.
Prof Hawthorne said the college 'supports a mixed-method approach to delivering care' in general practice and decisions on how appointments are carried out are between clinicians and patients.
'What's key is that when GPs are consulting with their patients remotely, they have access to the robust and up-to-date IT systems that allows them to do so safely and effectively,' she added.
Prof Hawthorne said the Government 'has put forward some encouraging proposals to improve the GP practice digital infrastructure and IT systems' but 'significant investment' is needed to make this a reality.
She added: 'The college has called for additional funding of at least £2 billion to ensure our physical and digital infrastructure is fit for purpose so we can offer patients the appointment that's right for them.'
A Department of Health and Social Care spokesperson said: 'We've made real progress fixing the front door of the NHS, recruiting more than 2,000 GPs in the last year and delivering an additional 7 million GP appointments to improve access for patients.
'Through our 10 Year Health Plan we are delivering Neighbourhood Health Services that deliver more personalised, proactive care in local areas where it is more convenient for patients.
'This Government is also clear that patients should have access to health and care when they need it and people who prefer a face-to-face appointment should have one, so we are transforming the NHS app to make managing your healthcare online easy and flexible.'
An NHS England spokesperson said: 'Every GP practice must offer face-to-face appointments where patients want or need them, and many patients choose remote appointments where it is clinically appropriate and more convenient for them.
'GP teams are working hard to offer better access for patients, with a record number of appointments being carried out in the last year and recent findings showing the number of patients who are satisfied with their practice has improved.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
GPs warned using AI to record patient notes can lead to dangerous inaccuracies
GPs have been warned to look out for 'inaccurate or fabricated' information when using AI to write their medical notes. Family doctors are increasingly using tools that listen to their consultations with patients and automatically add summaries to their records. But the Royal College of GPs has warned AI can misinterpret the nuance of conversations, with potential dangerous consequences. The Medicines and Healthcare products Regulatory Agency (MHRA) also says there is a 'risk of hallucination which users should be aware of, and manufacturers should actively seek to minimise and mitigate the potential harms of their occurrence'. The safety watchdog is now urging GPs to report issues with AI scribes through its Yellow Card Scheme, which is typically used to report adverse reactions to medicines. This should include 'suspected inaccuracies', trade publication GP Online reports. The British Medical Association's GP Committee said earlier this year that 'the adoption of passive scribes in general practice has gathered significant pace', with practices using standalone systems or tools rolled out with other common software. Dr Phil Whitaker, a UK GP who recently moved to Canada, wrote in the New Statesman that an AI tool he used was 'not to be trusted'. He said it misinterpreted conversations with patients who asked him about his move from the UK - and recorded notes suggesting patients had recently moved to Canada instead. He added: 'I've caught it recording findings of examinations I haven't performed and detailing advice I haven't given. 'The company that makes it advises users to check its output carefully. 'For me, the time spent reading and editing outweighs any productivity gains.' And an article published by Fortune last month outlined a case in which 'a patient in London was mistakenly invited to a diabetic screening after an AI-generated medical record falsely claimed he had diabetes and suspected heart disease'. However, despite this growing use of AI and the recognition of potential problems, the MHRA said a search of its database revealed 'no adverse incident reports related to the use of AI scribes'. The government's 10-Year Health Plan says it intends to 'accelerate the adoption and spread of AI technology, such as AI scribes, by streamlining AI regulation'. A new national procurement platform will be set up next year to support GP practices and NHS trusts to adopt new technology safely. Professor Kamila Hawthorne, chair of the RCGP, said: 'AI has enormous potential for transforming the future of our health and patient care. Fewer than one in three Britons are comfortable with the prospect of using new AI features in the NHS App to diagnose their issues, a poll reveals. Health secretary Wes Streeting announced plans to revamp the app as part of Labour's 10-Year Health Plan so every patient could have a 'doctor in their pocket'. But a new survey found 44 per of the public are 'uncomfortable' with trusting the diagnosis and management of their conditions to artificial intelligence, with this figure rising to 60 per cent among pensioners. Only 31 per cent of the 2,030 respondents to the Savanta poll, for the Liberal Democrats, said they are 'comfortable' with the idea. Helen Morgan, the Liberal Democrat's health spokesperson, praised Labour for tackling bureaucracy but added: 'Making the NHS more efficient is of course welcome but it cannot come at the cost of leaving people behind as they try to grapple with digitised services rather than a real life doctor. 'Ministers need to allay these fears by offering support to those who are not digitally literate and older people to ensure that these sweeping changes benefit everyone.' Speaking at the Plan's launch last month, Mr Streeting said: 'The NHS App will become a doctor in your pocket, bringing our health service into the 21st century.' It will use patients' medical records and artificial intelligence to provide instant answers to users' questions and direct them to the best place for care. Dennis Reed, director of Silver Voices, which campaigns for elderly Britons, said at the time 'Elderly people will be sceptical about whether the plan will be delivered and concerned that greater reliance on the app could exclude them from accessing timely care. 'For some, the doctor in their pocket will be padlocked.' 'However, its use is not without risks and so its implementation in general practice must be closely regulated to guarantee patient safety and the security of their data. 'GPs are always open to introducing new technologies that can improve the experience of patients and help cut the administrative burden, and an increasing number of GP practices are now using AI scribing tools to improve the quality and efficiency of their consultations. 'While these tools can offer real benefits, particularly at a time of significant GP workforce pressures, there are some important concerns - particularly around data security of sensitive patient records, data controllership and the risk of inaccuracies. 'We are aware that AI scribes can produce inaccurate or fabricated details, and that they can also misinterpret the nuance of conversations. 'It is important that clinicians review AI-generated documentation for accuracy before adding it to the patient record.' The MHRA said: 'The MHRA is aware of this potential issue in AI enabled tools generally and this includes AI scribe tools. 'We recommend that GPs and healthcare professionals only use tools which are registered medical devices which have been determined to meet the required standards of performance and safety. 'Recently published MHRA guidance clarifies how these technologies qualify as medical devices and while this is specific to digital mental health, the principles apply across digital health applications. 'While not published by the MHRA, NHS England guidance encourages the use only of registered medical devices when used in a clinical context. 'We strongly encourage that all suspected adverse incidents, including suspected inaccuracies are reported to the MHRA via the yellow card scheme.' The watchdog said the yellow card scheme website had been updated to include 'a standalone page for software and AI as medical device'. Earlier this year, the BMA advised practices to pause use of AI scribes until they had carried out data protection and safety checks and sought assurances that the products meet NHS standards.
The Guardian
4 hours ago
- The Guardian
Covid cases rising in US as officials plan to restrict booster vaccines
Covid is on the rise again in the US, as children begin returning to school and as officials plan to restrict booster shots. While cases are increasing less quickly than at the start of other surges, it is too soon to tell how big the current late-summer wave could get – and with highly varied immune responses from prior infections and vaccinations, it is difficult to know how severe illness could be, experts said. The risks of a wave are compounded by new vaccine restrictions from the Trump administration. 'If you're vaccinated against Covid-19, you're less likely to get infected,' said Andrew Pekosz, a virologist at Johns Hopkins University. 'But we haven't gotten a lot of people vaccinated for the past few years, and with the current recommendations changing, it's even less likely.' Future waves could become more severe as vaccination lags and immunity drops, Pekosz said. Several key measurements – including wastewater data, test positivity and emergency room visits – indicate a new rise in infections. In the past, Covid has surged about twice a year, usually in the summer and the winter. But the pattern can change, as it does with other respiratory viruses – with late or early starts to the season and curveballs like double peaks. 'Each year has been different, so in some ways, this is more of the same,' said Sam Scarpino, a professor of health sciences at Northeastern University. Cases are increasing or probably increasing in 26 US states, especially in the south and midwest, according to the US Centers for Disease Control and Prevention (CDC). 'In the snapshot that we're seeing right now, increases are happening at a relatively low rate, and that would indicate that we probably aren't going to peak at a very high level. But again, this is early in this summer surge, so we really have to keep monitoring the data and paying attention to what it's telling us,' Pekosz said. The variants currently spreading around the globe have known immune-evasion properties, Scarpino said. 'You can look at the rise that we're seeing, the fact that we know it's an immune-escape variant, and I think we can be pretty confident that there's some kind of wave coming,' Scarpino said. 'Whether it's going to be large or small, I don't think we could really say one way or the other.' But 'the vaccines are still providing some protection,' he said. 'It's never too late to get the booster.' Yet officials softened the recommendation for children on Covid vaccines, and they removed the suggestion entirely for pregnant people, despite the clear benefits of the shot in reducing the risk of severe illness and death during pregnancy. A new, more effective Covid shot from Moderna and the Covid shot from Novavax were approved only for people over 65 or people over the age of 12 with health conditions. The independent advisers to the US Food and Drug Administration (FDA) recommended that vaccine manufacturers once again update booster shots this fall to a more recent variant. Covid boosters are usually recommended for all adults. But this fall, the boosters may be limited to older people and those with health conditions, FDA officials wrote in May. 'So it's a big question mark, going into the fall, is who it's going to be approved for,' Scarpino said. 'If it's not approved, can you still pay out of pocket for it? How much is it going to cost? And then are there going to be supply chain issues?' Health officials have also called for placebo trials for the boosters to judge their benefit to people without pre-existing conditions – but such trials would be unethical and extremely difficult to conduct, experts say. 'Clearly, the guidelines right now are focused on the populations that are more prone to have severe disease and severe outcomes. It's always been good to vaccinate that population,' Pekosz said. But the Trump administration is moving away from the approach of immunizing broad swaths of the population – especially those most likely to get and pass the virus on, like children, he said. 'If you vaccinate broadly, you can reduce the spread of Covid-19 in the population,' Pekosz said. 'The benefit, to me, is very clearly on the side of getting vaccinated.' Some of the pre-existing conditions proposed by FDA officials include asthma, diabetes, depression and physical inactivity. According to that list, 'basically everybody's eligible for one of the vaccines,' Scarpino said. And doctors, including pediatricians, may also prescribe vaccines for off-label use. Yet the more restrictions are placed on vaccination, the harder it is to reach even the people who need it most, Pekosz noted. Antivirals like Paxlovid could also see wider use, the experts said. 'We shouldn't forget about the antivirals,' Pekosz said. 'Those don't seem to be the target of more restrictive use by the CDC or the FDA, so those will be available for people if they do get infected.' A program to make Paxlovid more affordable to those who need it is slated to end in December. 'The benefits of antiviral treatment are very clear with respect to hospitalization and mortality decreases,' Pekosz said. Paxlovid is still highly effective against current variants, Scarpino said. 'There's a whole bunch of good reasons to get it.' Rates of hospitalizations and deaths in recent waves have dropped among adults compared with earlier Covid waves, but the virus remains deadly. An estimated 35,000 to 54,000 people in the US have died of Covid since October. Children continue to see hospitalizations rates from Covid similar to previous years. Covid cases can be less severe because of immunity – from prior infection or from vaccination. 'It's not so much that the virus has become less dangerous, it's that we have immunity, so we fight off the virus more efficiently than we did early in the pandemic,' Pekosz said. That's why vaccinations remain a key part of controlling Covid, he said. Without boosters, people become more susceptible to severe illness and death. About 23% of adults had received updated Covid boosters as of April. About 5.6% of children aged six months to four years are vaccinated against Covid, and about 15% of children aged five to 17 are vaccinated, according to the CDC. 'Children's cases are always surging, because children don't have much immunity to Covid,' Pekosz said. 'Covid cases are really occurring in children at a very high level right now. It's not nearly as dangerous in children as it is in adults, but it still causes a lot of hospitalizations in children.' Hospitalizations and deaths are not the only ways to measure the damage and disruption wrought by Covid. While the Trump administration has not released updated data on long Covid, an estimated 5.3% of all adults in the US said they were currently experiencing long-term Covid symptoms as of September. Even in times of lower transmission, Covid still circulates, with 149 deaths in the week ending 28 June, the last week for which the CDC shares full mortality data. 'It's still a little surprising that it's around all year,' said Pekosz. During lull times, 'we're not seeing it disappear completely, like we do with other respiratory viruses.' When it comes to keeping rates of Covid low, 'it's all the same stuff we usually go over,' Pekosz said – getting vaccinated, taking precautions like masking and using air purifiers, and staying home if you're sick. 'But it's just a very different environment these days. When the government doesn't use the science to drive their decision making, you can see the confusion that it puts into the general public.'
The Guardian
6 hours ago
- The Guardian
Covid cases rising in US as officials plan to restrict booster vaccines
Covid is on the rise again in the US, as children begin returning to school and as officials plan to restrict booster shots. While cases are increasing less quickly than at the start of other surges, it is too soon to tell how big the current late-summer wave could get – and with highly varied immune responses from prior infections and vaccinations, it is difficult to know how severe illness could be, experts said. The risks of a wave are compounded by new vaccine restrictions from the Trump administration. 'If you're vaccinated against Covid-19, you're less likely to get infected,' said Andrew Pekosz, a virologist at Johns Hopkins University. 'But we haven't gotten a lot of people vaccinated for the past few years, and with the current recommendations changing, it's even less likely.' Future waves could become more severe as vaccination lags and immunity drops, Pekosz said. Several key measurements – including wastewater data, test positivity and emergency room visits – indicate a new rise in infections. In the past, Covid has surged about twice a year, usually in the summer and the winter. But the pattern can change, as it does with other respiratory viruses – with late or early starts to the season and curveballs like double peaks. 'Each year has been different, so in some ways, this is more of the same,' said Sam Scarpino, a professor of health sciences at Northeastern University. Cases are increasing or likely increasing in 26 US states, especially in the south and midwest, according to the US Centers for Disease Control and Prevention (CDC). 'In the snapshot that we're seeing right now, increases are happening at a relatively low rate, and that would indicate that we probably aren't going to peak at a very high level. But again, this is early in this summer surge, so we really have to keep monitoring the data and paying attention to what it's telling us,' Pekosz said. The variants currently spreading around the globe have known immune-evasion properties, Scarpino said. 'You can look at the rise that we're seeing, the fact that we know it's an immune-escape variant, and I think we can be pretty confident that there's some kind of wave coming,' Scarpino said. 'Whether it's going to be large or small, I don't think we could really say one way or the other.' But 'the vaccines are still providing some protection,' he said. 'It's never too late to get the booster.' Yet officials softened the recommendation for children on Covid vaccines, and they removed the suggestion entirely for pregnant people, despite the clear benefits of the shot in reducing the risk of severe illness and death during pregnancy. A new, more effective Covid shot from Moderna and the Covid shot from Novavax were approved only for people over 65 or people over the age of 12 with health conditions. The independent advisers to the US Food and Drug Administration (FDA) recommended that vaccine manufacturers once again update booster shots this fall to a more recent variant. Covid boosters are usually recommended for all adults. But this fall, the boosters may be limited to older people and those with health conditions, FDA officials wrote in May. 'So it's a big question mark, going into the fall, is who it's going to be approved for,' Scarpino said. 'If it's not approved, can you still pay out of pocket for it? How much is it going to cost? And then are there going to be supply chain issues?' Health officials have also called for placebo trials for the boosters to judge their benefit to people without pre-existing conditions – but such trials would be unethical and extremely difficult to conduct, experts say. 'Clearly, the guidelines right now are focused on the populations that are more prone to have severe disease and severe outcomes. It's always been good to vaccinate that population,' Pekosz said. But the Trump administration is moving away from the approach of immunizing broad swaths of the population – especially those most likely to get and pass the virus on, like children, he said. 'If you vaccinate broadly, you can reduce the spread of Covid-19 in the population,' Pekosz said. 'The benefit, to me, is very clearly on the side of getting vaccinated.' Some of the pre-existing conditions proposed by FDA officials include asthma, diabetes, depression and physical inactivity. According to that list, 'basically everybody's eligible for one of the vaccines,' Scarpino said. And doctors, including pediatricians, may also prescribe vaccines for off-label use. Yet the more restrictions are placed on vaccination, the harder it is to reach even the people who need it most, Pekosz noted. Antivirals like Paxlovid could also see wider use, the experts said. 'We shouldn't forget about the antivirals,' Pekosz said. 'Those don't seem to be the target of more restrictive use by the CDC or the FDA, so those will be available for people if they do get infected.' A program to make Paxlovid more affordable to those who need it is slated to end in December. 'The benefits of antiviral treatment are very clear with respect to hospitalization and mortality decreases,' Pekosz said. Paxlovid is still highly effective against current variants, Scarpino said. 'There's a whole bunch of good reasons to get it.' Rates of hospitalizations and deaths in recent waves have dropped among adults compared to earlier Covid waves, but the virus remains deadly. An estimated 35,000 to 54,000 people in the US have died of Covid since October. Children continue to see hospitalizations rates from Covid similar to previous years. Covid cases can be less severe because of immunity – from prior infection or from vaccination. 'It's not so much that the virus has become less dangerous, it's that we have immunity, so we fight off the virus more efficiently than we did early in the pandemic,' Pekosz said. That's why vaccinations remain a key part of controlling Covid, he said. Without boosters, people become more susceptible to severe illness and death. Some 23% of adults had received updated Covid boosters as of April. About 5.6% of children aged six months to four years are vaccinated against Covid, and about 15% of children aged five to 17 are vaccinated, according to the CDC. 'Children's cases are always surging, because children don't have much immunity to Covid,' Pekosz said. 'Covid cases are really occurring in children at a very high level right now. It's not nearly as dangerous in children as is in adults, but it still causes a lot of hospitalizations in children.' Hospitalizations and deaths are not the only ways to measure the damage and disruption wrought by Covid. While the Trump administration has not released updated data on long Covid, an estimated 5.3% of all adults in the US said they were currently experiencing long-term Covid symptoms as of September. Even in times of lower transmission, Covid still circulates, with 149 deaths in the week ending June 28, the last week for which the CDC shares full mortality data. 'It's still a little surprising that it's around all year,' said Pekosz. During lull times, 'we're not seeing it disappear completely, like we do with other respiratory viruses.' When it comes to keeping rates of Covid low, 'it's all the same stuff we usually go over,' Pekosz said – getting vaccinated, taking precautions like masking and using air purifiers, and staying home if you're sick. 'But it's just a very different environment these days. When the government doesn't use the science to drive their decision making, you can see the confusion that it puts into the general public.'
